Advertisement Article continues below this ad Yet, this lack of bespoke options is more or less the reality of medicine today. Despite the many biological differences between people of different ...
Understanding ad effectiveness is key to successful marketing, yet marketers often shy away from the most reliable tools for ...
The Vancouver-based company uses generative AI to create biologic drugs, with 20 “active programs” underway, many of them ...
GlobalData’s Revati Tatake discussed key trends in biopharma which are set to have an impact in 2025 and beyond.
Financial writer discusses Coya Therapeutics, Inc.'s Treg therapies for neurodegenerative diseases like ALS, FTD, and PD.
Advertisement If successful, these trials could revolutionize organ transplantation, helping address the severe shortage of ...
I worked closely with NCI’s Investigational Drug Branch (IDB) from 1990-2016, including as a principal investigator of one of ...
In the last 5 years significant progress has been made in potential dementia treatments, yet many of these treatments come ...
Uganda's highest judicial authority declared on Friday that prosecuting civilians in military courts is unconstitutional, ordering an immediate halt to such trials. The landmark decision benefits ...
And mercifully, a ball is about to be kicked in anger. Rugby league trials are upon us, with Las Vegas venturers Cronulla, Penrith, Canberra and the Warriors all taking the paddock for the first ...
“Now with the advance in breeding technology we have the possibility to draw from many hundreds of new grape varieties which will allow us to deliver exactly what our customers want, and that’s the ...
FY25 saw AdAlta (ASX:1AD) focus on increasing its corporate muscle, with two new board members and additional advisors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results